Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

e-Therapeutics to Offer Computational Biotech Services from Nanjing Office

publication date: Jan 9, 2009

e-Therapeutics, a British software firm offering a computational biotechnology platform, has opened an office in Nanjing that will allow the company to collaborate with biopharmas in China. The company’s software models the interactions of a given compound, predicting the degree to which it will bind with the body’s proteins. It can be used in drug discovery programs to predict efficacy as well as unwanted interactions. In September 2008, e-Therapeutics announced a partnership with Nanjing KeyGen Biotech. Co. Limited. More details...

Stock Symbols: (AIM: ETX) (SHA: 600713)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital